Unilateral Sequential Sympathectomy for Palmar Hyperhidrosis

NCT ID: NCT02321332

Last Updated: 2014-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-06-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison between unilateral sequential and bilateral simultaneous endoscopic thoracic sympathectomy for palmar hyperhidrosis on patients outcomes notably compensatory hyperhidrosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Palmar Hyperhidrosis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Palmar hyperhidrosis Endoscopic thoracic sympathectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

B-ETS

Bilateral simultaneous endoscopic thoracic sympathectomy: bilateral simultaneous T2-T3 ganglionectomy.

Group Type ACTIVE_COMPARATOR

bilateral simultaneous endoscopic thoracic symapthectomy

Intervention Type PROCEDURE

Patients underwent bilateral simultaneous T2-T3 ganglionectomy using thoracoscopic approach.

S-ETS

unilateral sequential endoscopic thoracic sympathectomy: unilateral T2-T3 ganglionectomy of the dominant side followed by T2-T3 ganglionectomy of the other side after 2 months interval

Group Type ACTIVE_COMPARATOR

unilateral sequential endoscopic thoracic symapthectomy.

Intervention Type PROCEDURE

Patients underwent unilateral T2-T3 ganglionectomy of the dominant side followed by T2-T3 ganglionectomy of the other side after 2 months interval.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bilateral simultaneous endoscopic thoracic symapthectomy

Patients underwent bilateral simultaneous T2-T3 ganglionectomy using thoracoscopic approach.

Intervention Type PROCEDURE

unilateral sequential endoscopic thoracic symapthectomy.

Patients underwent unilateral T2-T3 ganglionectomy of the dominant side followed by T2-T3 ganglionectomy of the other side after 2 months interval.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients suffering palmar hyperhidrosis

Exclusion Criteria

* Patients with pleural adhesions, bleeding diathesis, local infection or previous operation for hyperhidrosis
Minimum Eligible Age

8 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tmaer Youssef Mohamed

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tmaer Youssef Mohamed

assistant professor of surgery

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

tamer youssef, MD

Role: STUDY_DIRECTOR

Mansoura Faculty of Medicine

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MFM2010344

Identifier Type: -

Identifier Source: org_study_id